Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy
{{output}}
With the increasing use of potent immunosuppressive therapy, reactivation of hepatitis B virus (HBV) in endemic regions is becoming a clinical problem requiring special attention. A recent annual nationwide survey clarified that HBV reactivation related to imm... ...